Answers are grounded in this paper and cite their sources.
Clinicopathological study uncovers abnormal cytoplasmic KIF1A aggregation without motor activity loss in an ALS patient, suggesting novel mislocalization mechanisms in pathogenesis.
KIF1A is the primary anterograde motor protein responsible for axonal transport of synaptic vesicle precursors and dense-core vesicles. Although heterozygous KIF1A variants have recently been proposed as candidate risk factors for amyotrophic lateral sclerosis (ALS), their neuropathological correlates remain unknown. We conducted a comprehensive clinicopathological study of a Japanese patient with ALS carrying a heterozygous p.I433V KIF1A variant and analysed the subcellular localization of KIF1A in distinct neuronal populations, with quantitative comparison performed in lumbar anterior horn cells among the KIF1A variant case, sporadic ALS (SALS) cases, and control subjects. In addition, the motor activity of recombinant KIF1A harboring the p.I433V variant was assessed using biochemical assays. Neuropathological examination showed lower motor neuron loss with mild corticospinal tract degeneration, accompanied by pleomorphic neuronal cytoplasmic inclusions (NCIs) immunoreactive for transactive response DNA-binding protein of 43 kDa (TDP-43) and the presence of Bunina bodies. In contrast to control and SALS cases, which showed predominantly nuclear KIF1A immunoreactivity, the KIF1A variant case exhibited marked cytoplasmic redistribution of KIF1A in spinal motor neurons, occasionally forming KIF1A-positive NCIs. Similar inclusions were also observed in the substantia nigra and showed partial spatial overlap with phosphorylated TDP-43. Biochemical analyses demonstrated no apparent impairment of kinesin motor activity or overall microtubule binding caused by the p.I433V substitution. This study provides the first neuropathological characterization of an ALS patient harboring a heterozygous p.I433V KIF1A variant of uncertain significance. These findings suggest that aberrant subcellular localization of KIF1A, rather than primary impairment of kinesin motor activity, may contribute to ALS pathogenesis through mechanisms beyond conventional axonal transport dysfunction. This observation expands the clinicopathological spectrum of ALS cases harboring KIF1A variants and suggests a potential relevance of altered subcellular localization of KIF1A in ALS.
No takes yet. Share an insight, caveat, or question.
Nakamura et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: